News

Otsuka intends to invest more than $300 million in an FDA-cleared software app that will apply cognitive therapy principals either with or without prescription drugs. 

Plus: ResApp files for CE Mark; researchers develop "pacemaker for the brain."

Ongoing FDA submissions and other HHS services are safe, but new regulatory filings will have to be put on hold.

At HIMSS, Dr. Richard Milani will share learnings and data from his health system's chronic condition management initatives.

The infant mortality rate in Franklin County, Ohio, has reached 8.2 deaths per 1,000 live births, with black babies at three times the risk of white infants. 

The prescription device detects each use and records it to a paired mobile app. 

At HIMSS19, University of Chicago Medicine's chief experience officer will describe an ongoing coaching program that aims to restore the connection between humans and the healthcare technologies serving them. 

Dr. Courneya will speak at HIMSS19 in Orlando at “Teaming up for change: Virtual care lessons.” 

Industry players see blockchain as a tool for administrative tasks but remain skeptical about cryptocurrency in healthcare. 

Federal officials are working on policy about the emerging technology deliberately, helping to set expectations for near- and medium-term healthcare applications.